Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The ECJ GSK Ruling: everyone’s a winner baby, that’s the truth...

This article was originally published in RAJ Devices

Executive Summary

The recent Ruling from the European Court of Justice (ECJ) in the GlaxoSmithKline (GSK) v. Greek wholesalers case has unsurprisingly been greeted by both sides as a partial victory. The Ruling, which essentially prevents a pharmaceutical company from restricting supplies in order to destroy parallel trade involving its product – unless the demands of the wholesaler/parallel trader are deemed “out of the ordinary”, is on the face of it a judgement that indeed easily lends itself to ambiguity.

Advertisement
Advertisement
UsernamePublicRestriction

Register

SC092937

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel